In addition, we synthesized a peptide to promote the degradation of PBRM1 by enhancing the interaction between PBRM1 and p62, providing a promising tumor therapeutic approach with PBRM1 inhibition and PD‐1 blockade (Figure6). Here, PBRM1 is linked to neoplasm.